Hoʻopili ʻia nā monomers fibrin i loko o ke koko e ka helu X III i hoʻāla ʻia, a laila hydrolyzed e ka plasmin hoʻāla e hana i kahi huahana degradation kikoʻī i kapa ʻia ʻo "fibrin degradation product (FDP)."ʻO D-Dimer ka FDP maʻalahi loa, a ʻo ka piʻi ʻana o kāna ʻike nui e hōʻike ana i ka mokuʻāina hypercoagulable a me ka hyperfibrinolysis lua i loko o vivo.No laila, he mea koʻikoʻi ka manaʻo o D-Dimer no ka hōʻoia ʻana, ka loiloi efficacy a me ka hoʻoholo prognosis o nā maʻi thrombotic.
Mai ka puka ʻana o COVID-19, me ka hohonu o nā hōʻike lapaʻau a me ka ʻike pathological o ka maʻi a me ka hōʻiliʻili ʻana o ka maʻi a me ka ʻike lapaʻau, hiki i nā mea maʻi koʻikoʻi me ka maʻi maʻi coronary hou ke hoʻomohala koke i ka maʻi ʻeha hanu.ʻO nā hōʻailona, septic shock, refractory metabolic acidosis, coagulation dysfunction, a me ka pau ʻole o ke kino.Hoʻokiʻekiʻe ʻia ka D-dimer i nā maʻi me ka maʻi pneumonia koʻikoʻi.
Pono nā poʻe maʻi maʻi koʻikoʻi e nānā i ka pilikia o ka thromboembolism venous (VTE) ma muli o ka hoʻomaha lōʻihi o ka moe a me ka hana coagulation abnormal.
I ka wā o ke kaʻina hana, pono e nānā i nā hōʻailona kūpono e like me ke kūlana, me nā māka myocardial, ka hana coagulation, a me nā mea ʻē aʻe. D-Dimer) hiki ke hoʻonui.
Hiki ke ʻike ʻia he koʻikoʻi ka nānā ʻana o D-Dimer e pili ana i ka hoʻopiʻi ʻana i ka holomua o COVID-19, no laila pehea ke ʻano o ia i nā maʻi ʻē aʻe?
1. ʻO ka thromboembolism
Ua hoʻohana nui ʻia ʻo D-Dimer i nā maʻi pili i ka venous thromboembolism (VTE), e like me ka thrombosis hohonu hohonu (DVT) a me ka pulmonary embolism (PE).Hiki i ka ho'āʻo D-Dimer maikaʻi ke hoʻoholo i ka DVT, a hiki ke hoʻohana ʻia ka ʻike D-Dimer e wānana i ka helu hoʻi o VTE.Ua ʻike ʻia ka haʻawina ʻo ka lākiō pōʻino o ka hoʻi hou ʻana o VTE i ka heluna kanaka me ke kiʻekiʻe kiʻekiʻe he 4.1 mau manawa o ka heluna kanaka me ka ʻike maʻamau.
ʻO D-Dimer kekahi o nā hōʻailona ʻike o PE.He kiʻekiʻe loa kona waiwai wānana maikaʻi ʻole, a ʻo kona koʻikoʻi ke kāpae ʻana i ka embolism pulmonary acute, ʻoi aku ka nui o nā maʻi me ka kānalua haʻahaʻa.No laila, no nā poʻe maʻi i manaʻo ʻia he embolism pulmonary acute, pono e hui pū ʻia ka ultrasonography o nā veins hohonu o nā ʻaoʻao haʻahaʻa a me ka hoʻokolokolo D-Dimer.
2. Hoʻolaha ʻia ka coagulation intravascular
ʻO ka Disseminated intravascular coagulation (DIC) kahi maʻi maʻi i hōʻike ʻia e ka hemorrhage a me ka hemahema microcirculatory ma muli o nā maʻi he nui.ʻO ke kaʻina hana e pili ana i nā ʻōnaehana he nui e like me ka coagulation, anticoagulation, a me ka fibrinolysis.Ua hoʻonuiʻia ka D-Dimer i ka wā mua o ka hoʻokumuʻana o DIC, a ua hoʻomauʻia ka hoʻonuiʻana o kona manaʻo ma mua o 10-fold i ka holomua o ka maʻi.No laila, hiki ke hoʻohana ʻia ʻo D-Dimer e like me kekahi o nā hōʻailona nui no ka ʻike mua a me ka nānā ʻana i ke kūlana o DIC.
3. ʻAotic dissection
Ua kuhikuhi ʻo "Chinese expert consensus on the diagnostic and treatment of aortic dissection" ʻo D-Dimer, ma ke ʻano he hoʻokolohua maʻamau no ka ʻokiʻoki aortic (AD), he mea koʻikoʻi loa ia no ka ʻike ʻana a me ka ʻokoʻa ʻokoʻa o ka dissection.Ke piʻi wikiwiki ka D-Dimer o ka mea maʻi, hiki ke ʻike ʻia ke piʻi ʻana o AD.I loko o 24 mau hola o ka hoʻomaka ʻana, i ka hiki ʻana o D-Dimer i ka waiwai koʻikoʻi o 500 µg/L, ʻo 100% kona naʻau no ka hoʻomaʻamaʻa ʻana i ka maʻi AD, a ʻo kona kikoʻī ʻo 67%, no laila hiki ke hoʻohana ʻia ma ke ʻano he kuhikuhi hoʻokaʻawale no ka ʻike ʻana o ka maʻi. Acute AD.
4. Atherosclerotic Cardiovascular Disease
ʻO ka maʻi cardiovascular Atherosclerotic kahi maʻi puʻuwai i hoʻokumu ʻia e ka arteriosclerotic plaque, e komo pū ana me ST-segment elevation acute myocardial infarction, non-ST-segment elevation acute myocardial infarction, a me unstable angina.Ma hope o ka haki ʻana o ka plaque, kahe ka necrotic core material i loko o ka plaque, e hoʻoulu ai i nā ʻāpana kahe o ke koko, ka hoʻoulu ʻana o ka ʻōnaehana coagulation, a me ka hoʻonui ʻana o D-Dimer.Hiki i nā poʻe maʻi maʻi naʻau coronary me D-Dimer kiʻekiʻe ke wānana i kahi pilikia kiʻekiʻe o ka AMI a hiki ke hoʻohana ʻia ma ke ʻano he hōʻailona e nānā i ke kūlana o ACS.
5. Thrombolytic therapy
Ua ʻike ʻia ka haʻawina a Latter e hiki ke hoʻonui i nā lāʻau thrombolytic like ʻole i ka D-Dimer, a hiki ke hoʻohana ʻia kona hoʻololi ʻana ma mua a ma hope o ka thrombolysis i mea hōʻailona no ka hoʻokolokolo ʻana i ka thrombolytic therapy.Ua hoʻonui koke ʻia kāna ʻike i ka waiwai kiʻekiʻe ma hope o ka thrombolysis, a hāʻule i hope i ka manawa pōkole me ka hoʻomaikaʻi nui ʻana i nā hōʻailona lapaʻau, e hōʻike ana i ka maikaʻi o ka mālama ʻana.
- Ua hoʻonui nui ʻia ke kiʻekiʻe o D-Dimer i ka hola 1 a i 6 mau hola ma hope o ka thrombolysis no ka infarction myocardial acute a me ka infarction cerebral.
- I ka wā o ka thrombolysis DVT, hiki mai ka piko D-Dimer ma 24 mau hola a ma hope paha